Cargando…

Targeting gliomas with STAT3-silencing nanoparticles

Glioblastoma is an aggressive brain tumor with poor prognosis. The brain is protected by the blood–brain barrier, which precludes transport of chemotherapeutics. We developed nanoparticles that achieve delivery of small-interfering RNA against Stat3 after systemic administration. Nanoparticles combi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadiyala, Padma, Gregory, Jason V., Lowenstein, Pedro R., Lahann, Joerg, Castro, Maria G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018361/ https://www.ncbi.nlm.nih.gov/pubmed/33855166 http://dx.doi.org/10.1080/23723556.2020.1870647

Ejemplares similares

Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
por: Gregory, Jason V., et al.
Publicado: (2020)

An Optimized Protocol for In Vivo Analysis of Tumor Cell Division in a Sleeping Beauty-Mediated Mouse Glioma Model
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2020)

The steep road to nonviral nanomedicines: Frequent challenges and culprits in designing nanoparticles for gene therapy
por: Yao, Yao, et al.
Publicado: (2023)

CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study
por: Yadav, Viveka Nand, et al.
Publicado: (2016)

A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
por: Shah, Diana, et al.
Publicado: (2021)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Necroptosis: STAT3 kills?
por: Georgiadis, Vassilis, et al.
Publicado: (2012)

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2021)

The STAT3-DNMT1 connection
por: Thomas, N. Shaun B.
Publicado: (2012)

Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches
por: Habibi, Nahal, et al.
Publicado: (2022)

Systematic studies into uniform synthetic protein nanoparticles
por: Habibi, Nahal, et al.
Publicado: (2022)

Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM
por: Assi, Hikmat, et al.
Publicado: (2014)

STAT3 as a new autophagy regulator
por: Jonchère, Barbara, et al.
Publicado: (2013)

Determinants of the extent and duration of STAT3 signaling
por: Groner, Bernd
Publicado: (2012)

The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
por: Ganguly, Debolina, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
por: Mineharu, Yohei, et al.
Publicado: (2013)

3131 ONCOSTREAMS: NOVEL DYNAMICS PATHOLOGICAL MULTICELLULAR STRUCTURES INVOLVED IN GLIOBLATOMA GROWTH AND INVASION
por: Comba, Andrea, et al.
Publicado: (2019)

The Magnetic Appeal of Silencing Theranostics
por: Bulte, Jeff W.M.
Publicado: (2012)

Synonymous Variants of Uncertain Silence
por: Giacoletto, Christopher J., et al.
Publicado: (2023)

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas
por: Faisal, Syed M., et al.
Publicado: (2020)

Role of STAT1 in the breast
por: Bailey, Sarah G., et al.
Publicado: (2012)

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition
por: Yeh, Jennifer E, et al.
Publicado: (2013)

STAT3, HIF-1, glucose addiction and Warburg effect
por: Darnell, James E.
Publicado: (2010)

H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2023)

Bit1 Silencing Enhances the Proliferation, Migration, and Invasion of Glioma Cells Through Activation of the IL-6/STAT3 Pathway
por: Wang, Zhengfeng, et al.
Publicado: (2020)

Circulating miRNAs as new activators of the JAK-STAT3 pathway
por: Lam, David, et al.
Publicado: (2013)

H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
por: Haase, Santiago, et al.
Publicado: (2022)

Genetically Engineered Mouse Model of Brainstem High-Grade Glioma
por: Nunez, Fernando M., et al.
Publicado: (2020)

Oncostatin-M Differentially Regulates Mesenchymal and Proneural Signature Genes in Gliomas via STAT3 Signaling()
por: Natesh, Kumar, et al.
Publicado: (2015)

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
por: Linder, Benedikt, et al.
Publicado: (2019)

Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
por: Haase, Santiago, et al.
Publicado: (2020)

Nanoparticles Targeting STATs in Cancer Therapy
por: Ashrafizadeh, Milad, et al.
Publicado: (2019)

PKM2, STAT3 and HIF-1α: The Warburg’s vicious circle
por: Demaria, Marco, et al.
Publicado: (2012)

STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context
por: Segatto, Ilenia, et al.
Publicado: (2018)

Tackling Pediatric Low-Grade Gliomas: A Global Perspective
por: Moreira, Daniel C., et al.
Publicado: (2023)

Reversibility of glioma stem cells’ phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery tool
por: Wilson, Thomas J., et al.
Publicado: (2016)

Impact of epigenetic reprogramming on antitumor immune responses in glioma
por: McClellan, Brandon L., et al.
Publicado: (2023)

JAK2-STAT3 signaling: A novel function and a novel mechanism
por: Hofmann, Hans-Dieter, et al.
Publicado: (2012)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Targeting microRNA-10 in glioma; a focus with potential therapeutic application in genome editing
por: Maus, Katharina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n6qbkdmp81b6n33rnfhvn0ffvt